Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

15/05/2025 07:40

May 15 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to  
                Mar 31, 2025        Mar 31, 2024      Dec 31, 2025 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            965 mln             648 mln            3.89     
                 (+48.8 pct)         (+75.1 pct)      (+25.1 pct)  
  Operating        93 mln              44 mln           118 mln    
                (+109.2 pct)                                       
  Recurring        29 mln            loss 77 mln         73 mln    
  Net            loss 5 mln          loss 78 mln      loss 71 mln  
  EPS           loss 0.24 yen       loss 3.61 yen    loss 3.25 yen 
  Ann Div                                NIL              NIL      
  -Q2 div                                NIL              NIL      
  -Q4 div                                NIL              NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T